Showing the latest 10 filings. Sign in to filter or browse the full history. View full history
Showing 10 of 11 filings.
14 Aug 2026 2 filings
Financials
Net sales / income from operations: Rs 22.11 lakhs for quarter ended 30.06.2026.
Total income: Rs 24.35 lakhs for quarter ended 30.06.2026.
PBT: Rs -188.41 lakhs for quarter ended 30.06.2026.
PAT: Rs -188.41 lakhs for quarter ended 30.06.2026.
EPS (Basic & Diluted): Rs -3.77 for quarter ended 30.06.2026.
Going concern & notes
Auditors flag material going concern uncertainty due to cash losses and eroded net worth.
Current liabilities exceed current assets as on balance sheet date.
Intangible assets
Intangible assets under development: Rs 2,431.02 lakhs; impairment prospects uncertain per notes.
Overdue statutory dues
Overdue statutory dues as of 30 Jun 2026 noted; includes GST/Sales Tax and TDS liabilities.
Q1 2026 results and auditor remarks
Board approved unaudited standalone results for quarter ended 30 June 2026 with Limited Review.
Net sales: Rs 22.11 Lacs.
Other income: Rs 2.24 Lacs; total income: Rs 24.35 Lacs.
Total expenses: Rs 212.76 Lacs.
Profit after tax: Rs -188.41 Lacs; EPS: Rs -3.77.
Auditor notes modified observations on overdue statutory dues.
Intangible assets under development Rs 2431.02 Lacs; auditor unable to comment.
Going concern: material uncertainty; management pursuing prospective investors.
Rent not recognised 2019-04-01 to 2024-07-31; Rs 607.15 Lacs; discussions ongoing.
Board meeting date: 14 August 2026; results prepared per Ind AS.
12 Aug 2026 1 filing
Meeting Details
Board meeting scheduled for 14 August 2026.
Venue: Corporate office, Brigade Champak, Infantry Rd, Shivaji Nagar, Bengaluru.
Key Agenda Items
Discuss and approve unaudited Q1 FY2026 results ending 30 June 2026 with balance sheet.
Other Notes
Trading window closed from 12 Aug 2026 until 48 hours after results declaration.
9 Feb 2026 1 filing
🗓️ Meeting Details
Board meeting scheduled for February 13, 2026, at the corporate office in Bengaluru.
📊 Financial Performance
Board to consider and approve unaudited financial results for Q3 ended December 31, 2025.
Approval of the statement of assets and liabilities as of December 31, 2025, on the agenda.